Skip Navigation
Menu
Editorials |5 September 2017

Cannabis for Pain and Posttraumatic Stress Disorder: More Consensus Than Controversy or Vice Versa?

Sachin Patel, MD, PhD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at Annals.org on 15 August 2017.
×
FULL TEXT
The scientific evidence for the effectiveness and safety of cannabis and cannabinoid products in treating medical and psychiatric disease has recently come under substantial scrutiny. This surge in methodologically rigorous analysis of the evidence supporting cannabis-based therapeutics is driven in part by recent, dramatic, and ongoing changes in the accessibility of cannabis caused by U.S. state-level antiprohibition movements. In this context, clinicians, policymakers, and the public are increasingly interested in understanding the scientific evidence base underlying potential indications for medical cannabis use. This issue of Annals of Internal Medicine includes 2 such analyses, 1 focusing on pain and the other on posttraumatic stress disorder (PTSD). The systematic reviews highlight an alarming lack of high-quality data from which to draw firm conclusions about the efficacy of cannabis for these conditions, for which cannabis is both sanctioned and commonly used.
Nugent and colleagues (1) systematically reviewed data on the effects of cannabis for several types of pain and found only limited, low-strength evidence that cannabis alleviates neuropathic pain and insufficient evidence for other types of pain. Of importance, their conclusions were heavily based on studies using nabiximols (an oral mixture of tetrahydrocannabinol and cannabidiol) rather than smoked cannabis products (2). In addition, the authors comment that most available studies are small, have methodological pitfalls, and are of relatively short duration. These conclusions seem at odds with the fact that pain is one of the most common medical conditions for which cannabis is used and approved in many states...
FULL TEXT
PDF
Not Available
Citations
Citation

Patel S. Cannabis for Pain and Posttraumatic Stress Disorder: More Consensus Than Controversy or Vice Versa?. Ann Intern Med. 2017;167:355–356. [Epub ahead of print 15 August 2017]. doi: https://doi.org/10.7326/M17-1713

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2017;167(5):355-356.

DOI: 10.7326/M17-1713

Published at www.annals.org on 15 August 2017

©
2017 American College of Physicians
2 Citations

Related Articles
The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review
Annals of Internal Medicine; 167 (5): 319-331
Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review
Annals of Internal Medicine; 167 (5): 332-340
Annals for Educators - 5 September 2017
Annals of Internal Medicine; 167 (5): ED5
Zen and the Art of Physician Autonomy Maintenance
Annals of Internal Medicine; 138 (12): 992-995
View MoreView Less

Journal Club
IV prochlorperazine + diphenhydramine improved migraine pain relief more than IV hydromorphone in the ED
Annals of Internal Medicine; 168 (6): JC28
Guideline: Experts recommend a single dose of oral steroids for pain relief in acute sore throat
Annals of Internal Medicine; 168 (2): JC2
Review: Weak evidence of benefits of cannabis for chronic neuropathic pain; moderate to weak evidence of adverse effects
Annals of Internal Medicine; 167 (12): JC62
An online exercise program plus automated coping skills training improved pain and function in chronic knee pain
Annals of Internal Medicine; 166 (12): JC67
View MoreView Less

Related Point of Care
Care of Returning Military Personnel
Annals of Internal Medicine; 159 (1): ITC1-1
Osteoarthritis
Annals of Internal Medicine; 147 (3): ITC8-1
Sickle Cell Disease
Annals of Internal Medicine; 155 (5): ITC3-1
Herpes Zoster
Annals of Internal Medicine; 154 (5): ITC3-1
View MoreView Less

Related Topics
Cardiac Diagnosis and Imaging
Cardiology

Cardiac Diagnosis and Imaging, Cardiology.

PubMed Articles
Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain.
Neuropsychopharmacology 2019.
Validation of the recently developed Total Disability Index: a single measure of disability in neck and back pain patients.
J Neurosurg Spine 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×